Home >> Tag Archives: Blueprint Medicines—

Tag Archives: Blueprint Medicines—

Horizon collaborates with Blueprint Medicines, 11/13

Horizon Discovery has signed a research service agreement with Blueprint Medicines, a patient-driven oncology company developing highly selective kinase inhibitors for genomically defined cancer subsets. Under the terms of the deal, Horizon will support Blueprint’s New Targets discovery platform by deploying its X-Man isogenic cell lines.

Read More »